Preetam Shah

Insider Reports History

Entity
Individual
Location
C/O Brainstorm Cell Therapeutics, Inc., 1325 Avenue Of Americas, 28 Th Flr., New York, NY
Signature
/s/ Shane Ward, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Preetam Shah:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Cidara Therapeutics, Inc. Chief Financial Officer Common Stock 336K $232K $0.69 Mar 15, 2024 Direct
Cidara Therapeutics, Inc. Chief Financial Officer Employee Stock Option (right to buy) 218K Mar 15, 2024 Direct
Cidara Therapeutics, Inc. Chief Financial Officer Employee Stock Option (right to buy) 130K Sep 30, 2024 Direct

Insider Reports Filed by Preetam Shah

Symbol Company Period Transactions Value $ Form Type Date Filed Role
CDTX Cidara Therapeutics, Inc. Sep 30, 2024 1 $0 4 Oct 2, 2024 Chief Financial Officer
CDTX Cidara Therapeutics, Inc. Mar 15, 2024 2 $0 4 Mar 20, 2024 CFO & CBO
CDTX Cidara Therapeutics, Inc. Mar 11, 2024 1 -$12.7K 4 Mar 12, 2024 CFO & CBO
CDTX Cidara Therapeutics, Inc. Mar 27, 2023 2 $0 4 Mar 29, 2023 CFO & CBO
CDTX Cidara Therapeutics, Inc. Mar 13, 2023 1 -$10.2K 4 Mar 13, 2023 CFO & CBO
CDTX Cidara Therapeutics, Inc. Sep 15, 2022 3 -$12K 4 Sep 19, 2022 CFO & CBO
CDTX Cidara Therapeutics, Inc. Mar 31, 2022 4 -$20.6K 4 Apr 4, 2022 CFO & CBO
CDTX Cidara Therapeutics, Inc. Nov 12, 2021 1 $30.8K 4 Nov 15, 2021 CFO & CBO
CDTX Cidara Therapeutics, Inc. Sep 1, 2021 2 $0 4 Sep 3, 2021 CFO & CBO
CDTX Cidara Therapeutics, Inc. Sep 1, 2021 0 $0 3 Sep 3, 2021 CFO & CBO